Clotiazepam

This classification denotes a sedative and hypnotic with the molecular formula C16H15ClN2OS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ZCN055599V, chemically known as 5-(o-chlorophenyl)-7-ethyl-1,3-dihydro-1-methyl-2h-thieno(2,3-e)-1,4-diazepin-2-one but generally known as clotiazepam, which bears US NIH Compound Identifier 2811. European Medicines Agency schedules Clotiazepam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06773MIG. The term CLOTIAZEPAM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 28, No. 10 1974, List 14). World Health Organization schedules clotiazepam in its Anatomical Therapeutic Chemical (ATC) Classification. CLOTIAZEPAM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule clotiazepam under HS 29349100 and SITC 51579. As of Q4 2014, CLOTIAZEPAM remains the US FDA Preferred Term for this commodity. Clotiazepam bears US NLM identifiers UMLS ID C0009073 and NCI Concept Code C80672. SMILES: CLC1C(C2=NCC(=O)N(C3SC(CC23)CC)C)CCCC1.